aTyr Pharma (LIFE) Financials

$38.85

$-0.87 (-2.19%)

As on 10-Sep-2026 16:00EDT

Market cap

$3,819 Mln

Revenue (TTM)

$587 Mln

P/E Ratio

--

P/B Ratio

4.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	586.53	387.61	254.93	159.75	10.39	0.01
Cost of Revenue	17.20	6.73	6.53	5.90	1.70	1.30
Gross Profit	569.33	380.88	248.40	153.85	10.39	-1.30
Operating Expenses	672.98	307.95	206.18	162.67	56.79	34.02
Operating Profit (EBIT)	-103.65	72.92	48.75	-2.91	-46.40	-34.02
Other Income	--	--	--	--	--	--
Profit before Tax	-100.36	75.74	53.94	2.28	-45.34	-33.78
Provision for Tax	6.06	4.59	--	--	-1.07	-1.31
Profit after Tax (Net Income)	-106.43	71.15	48.83	1.69	-44.28	-32.46
Minority Interest	--	--	--	--	0.01	0.01
Consolidated Profit	--	--	--	--	-45.34	-33.77

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	476.17	-24.12	-107.15	-159.18	71.28	109.13
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	209.40	426.26	435.43	411.74	10.64	0.40
Current Liabilities	10.52	113.19	67.60	27.09	13.86	6.01
Total Liabilities	706.61	515.34	395.88	279.65	95.79	115.54

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	146.27	269.53	221.08	130.78	14.70	1.81
Current Assets	549.81	245.80	174.81	148.88	81.09	113.73
Total Assets	1,142.94	515.34	395.88	279.65	95.79	115.54
Total Debt*	20.00	2.35	--	--	11.53	1.38
Net Current Assets	102.96	132.61	107.21	121.78	67.01	107.71

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	36.23	-10.91	-37.12	-41.89	-33.08
Cash Flow from Investing Activities	--	31.87	--	--	47.25	-91.57
Cash from Financing Activities	--	-12.05	21.86	-1.64	5.45	110.03
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.51	1.14	0.78	--	--	--
Cash EPS ($)	--	1.24	0.87	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.58	-0.17	--	--	--
Free Cash Flow per Share ($)	--	0.48	-0.25	--	--	--

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-110.39	-36.67	-4.42	-45.81	-45.02
ROE (%)	--	-108.41	-36.67	-3.84	-49.08	-46.18
ROA (%)	-10.69	15.62	14.46	0.90	-41.90	-42.09
EBIT Margin (%)	-16.63	20.36	--	--	-446.79	-316,389.17
Net Margin (%)	-18.14	18.36	19.16	1.06	-426.31	-301,962.61
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	0.52	0.60	14.38	965.05	-1.00
EBIT Growth (%)	--	--	--	--	-36.42	-113.78
Net Profit Growth (%)	--	45.71	2,791.18	103.81	-36.39	-117.03
EPS Growth (%)	--	0.46	--	--	--	--
Book Value Growth (%)	34.53	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	--	--	--	--	--
Price / Book Value	4.93	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	17.25	--	--	--	1.22	3.26
Close Price ($)	18.14	--	--	1.41	2.19	7.47
High Price ($)	32.50	--	--	2.70	8.25	13.10
Low Price ($)	9.69	--	--	1.08	2.00	3.48
Market Cap ($ Cr)	3,819.16	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-0.10	--	--	0.16	0.01
Short term debt to equity ratio	0.02	-0.05	--	--	0.01	0.01
Current Ratio	52.25	2.17	2.59	5.49	5.85	18.91
Quick Ratio	52.25	--	--	--	6.06	--
Interest Coverage	-34.48	24.89	--	--	-27.38	-142.92

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	65.04	16.84	17.80	11.10	113.37	4,046.14
Asset Turnover	0.59	0.85	0.75	0.85	0.10	0.00
Receivable days	--	52.14	45.21	33.73	214.70	42,025.32
Inventory Days	--	--	--	-182.56	-635.69	--
Payable days	--	2,726.08	1,307.87	500.16	445.73	344.80
Cash Conversion Cycle	--	--	--	-649.00	-866.72	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.